Pharma News: CPhI South East Asia Opens Next Week in Jakarta, Indonesia

A press conference was held on March 16^th and saw the participation of Mr. Wiwy Sasongko -- General Manager Quintiles IMS Indonesia, Mr. Kendrariadi Suhanda -- Chairman of the Pharma Materials Management Club (PMMC) and Deputy secretary general at Indonesian Pharmaceutical Association (GP Farmasi), Mr. Teddy Iman Soewahjo -- Executive Director and Head of Packed Ingredients Division of PMMC, Mr. Vincent Harijanto -- Head of GP Farmasi's Research and Development of Raw Ingredients Trade and Industry and Vice Chairman of PMMC and Mr. Ivan Ferrari -- General Manager, PT UBM Pameran Niaga Indonesia.

Several key topics, relevant to the region, were discussed. In fact, the slowing pace of global markets and the increasing threat of a new protectionist wave is transforming the outlook of South East Asian manufacturers which are now shifting their focus more on the actual prospects of regional exports. Mirroring this trend, international investors and companies are now pushing for more business in this regional market, across the entire ASEAN economy.

Comprising of 40% of the SEA economic output, Indonesia is the largest pharma market in the South East Asia Pacific region (SEA/AP). The country has the biggest and fastest growing economy in the SEA region and a pharma economy consisting of over 200 pharmaceutical companies. There are already 25-30 generic domestic companies with access to the international market, and equally, there are approximately 35 multinational companies established in the area.

These favourable macro trends are reflected at CPhI South East Asia where domestic manufacturers in particular are increasingly attending the event, with a view to opening up sales in international markets. As the biggest pharma event in the ASEAN region, CPhI South East Asia will gather over 5,500 attendees from 41 countries and more than 260 exhibitors (click here for the full list) to network, learn and do business for three days. Co-locating this year with Health Ingredients South East Asia, the event welcomes the best pharma ingredients professionals, packaging experts, machinery providers and contract manufacturing as well as nutraceutical companies from across the region.

The event's conference programme is a dedicated, content-enriched platform that will cover business outlook and markets, regulations and compliance, and manufacturing and supply chain. Sessions include "Strategies to improve market access", "Effective compliance strategies when managing 3rd parties" and "Big Data trends and applications in Supply Chain" and panel discussions on "A look at the pharmaceutical industry in South East Asia" and "ASEAN regulatory harmonization developments".

The event is supported by the national and regional governments and regional trade groups, such as: the Ministry of Health, Ministry of Industry, Indonesia Investment Coordinating Board, National Agency for Drug and Food Control.

Highlighted features at CPhI South East Asia in 2017 include:

• The Investment Forum, matching key international players interested in investing in Indonesia with the top tier pharma companies in the country looking for reliable partners.
• All distributors in the region have been invited to visit the event and network with peers and exhibitors through CPhI South East Asia's Distributor Network -- expanding its database of providers in the region with the aim of magnifying the reach throughout the whole ASEAN region.
• The Business Matchmaking programme provides attendees with the opportunity to browse potential clients, schedule meetings before the event, and find new business partners.
• Roadshows have been organized in many ASEAN countries to further promote CPhI South East Asia as a pharma bridge in the region.

For more information please visit: http://www.cphi.com/sea/         

About CPhI

CPhI brings together more than 100,000 pharmaceutical professionals each year. CPhI hosts events in Europe, Korea, China, India, Japan, Southeast Asia, Istanbul and Russia.

Ivan Ferrari
+62-21-2930-5959
[email protected]

SOURCE CPhI SEA

Related Links

http://www.cphi.com/sea